4//SEC Filing
Aegerion Pharmaceuticals, Inc. 4
Accession 0001209191-15-001608
CIK 0001338042operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:50 PM ET
Size
5.6 KB
Accession
0001209191-15-001608
Insider Transaction Report
Form 4
Fitzpatrick Mark J.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2014-12-31+65,000→ 65,000 totalExercise: $15.95Exp: 2022-01-23→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]On January 23, 2012, the reporting person was granted an option to purchase 65,000 shares of common stock, subject to time and performance vesting criteria. The time and performance criteria have been met with respect to this award.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338042
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:50 PM ET
- Size
- 5.6 KB